Clinical Trial

Real-world of AI in Diagnosing Retinal Diseases

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to apply an artificial intelligence algorithm to diagnose multi-retinal diseases in real-world settings. The effectiveness and accuracy of this algorithm are evaluated by sensitivity, specificity, positive predictive value, negative predictive value, and area under curve.
Trial Details
NCT Number NCT05981950
Lead Sponsor Beijing Tongren Hospital
Conditions Artificial Intelligence, Retinal Diseases
Enrollment 100,000 participants
Start Date 2023-08-01
Primary Completion 2028-08-01 (estimated)
Study Completion 2029-08-01 (estimated)
Updated on ClinicalTrials.gov 2023-08-08